Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.010
Buy
RSI(14)
55.910
Neutral
STOCH(KDJ)(9,3,3)
41.615
Neutral
ATR(14)
0.044
High Vlolatility
CCI(14)
-12.491
Neutral
Williams %R
37.402
Buy
TRIX(12,20)
0.990
Buy
StochRSI(14)
31.048
Sell
Search
OSR Holdings Inc
OSRHAdd to Watchlist
0.448USD
+0.018+4.19%
Close 07-31 16:00（ET）Quotes delayed by 15 min
14.92MMarket Cap
16.13P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+4.19%
5 Days
+5.96%
1 Month
+41.64%
6 Months
-23.29%
Year to Date
-20.58%
1 Year
-34.90%
Key Figures
0.431Open
0.450High
476.35KVolume
16.13P/E TTM
--P/E Dynamic
--Dividend TTM
1.43%Turnover Ratio
0.430Prev. Close
0.411Low
154.93KTurnover
LossP/E Static
0.14P/B
0.00%Div Yield TTM
-11.04%ROA
1.79052wk High
1.14Volume Ratio
-2.41MNet Profit
33.30MShares
0.0278EPS TTM
--Beta
-10.63%ROE
0.38052wk Low
9.02%Amplitude
33.11%Gross Margin
14.92MMarket Cap
4.58Reward/Risk
7.44%Risk Rate
TradingKey Stock Score of OSR Holdings Inc
Currency: USD Updated: 2026-07-31Key Insights
OSR Holdings Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 99 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 10.00.In the medium term, the stock price is expected to trend down.Despite a strong stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
OSR Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
OSR Holdings Inc Highlights
StrengthsRisks
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company’s subsidiary, Vaximm’s flagship asset, VXM01, is a late clinical-stage (NCT037500701) immuno-oncology candidate for glioblastoma. Vaximm has three clinical and pre-clinical drug candidates targeting diseases ranging from glioblastoma to gastrointestinal stromal tumor to ocular diseases. The Company has operations in Europe and South Korea.
Growing
The company is in a growing phase, with the latest annual income totaling USD 2.91M.
Overvalued
The company’s latest PE is 16.13, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 220.68K shares, decreasing 93.19% quarter-over-quarter.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
10.000
Target Price
+2009.70%
Upside Space
OSR Holdings Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Buy
Current Rating
10.000
Target Price
+2009.70%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
OSR Holdings Inc
OSRH
1
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
0.448
Sell
MA10
0.445
Buy
MA20
0.407
Buy
MA50
0.403
Buy
MA100
0.474
Sell
MA200
0.535
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
OSR Holdings Inc Info
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company’s subsidiary, Vaximm’s flagship asset, VXM01, is a late clinical-stage (NCT037500701) immuno-oncology candidate for glioblastoma. Vaximm has three clinical and pre-clinical drug candidates targeting diseases ranging from glioblastoma to gastrointestinal stromal tumor to ocular diseases. The Company has operations in Europe and South Korea.
Ticker SymbolOSRH
CompanyOSR Holdings Inc
CEOHwang (Kuk Hyoun)
Websitehttps://osr-holdings.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-0.92%
-2.51%
+0.32%
-1.45%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
+1.30%
-0.90%
-2.15%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of OSR Holdings Inc (OSRH)?
The current price of OSR Holdings Inc (OSRH) is 0.45.
What is the symbol of OSR Holdings Inc?
The ticker symbol of OSR Holdings Inc is OSRH.
What is the 52-week high of OSR Holdings Inc?
The 52-week high of OSR Holdings Inc is 1.79.
What is the 52-week low of OSR Holdings Inc?
The 52-week low of OSR Holdings Inc is 0.38.
What is the market capitalization of OSR Holdings Inc?
The market capitalization of OSR Holdings Inc is 14.92M.
Is OSR Holdings Inc (OSRH) currently rated as Buy, Hold, or Sell?
According to analysts, OSR Holdings Inc (OSRH) has an overall rating of Buy, with a price target of 10.00.
What is the Earnings Per Share (EPS TTM) of OSR Holdings Inc (OSRH)?
The Earnings Per Share (EPS TTM) of OSR Holdings Inc (OSRH) is -0.92.